Wat is de prijs voor Dong Sung Bio Pharm.Co.,Ltd. (002210)

Het prijs van Dong Sung Bio Pharm.Co.,Ltd. (002210) is $1.11

Wat is de marktkapitalisatie voor Dong Sung Bio Pharm.Co.,Ltd. (002210)

Marktkapitalisatie voorDong Sung Bio Pharm.Co.,Ltd. (002210) is $27.12M

Dong Sung Bio Pharm.Co.,Ltd. (002210) K/O-verhouding

Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.

Jaar	P/S-ratio	Wijzigen
2026 (TTM)	0.52	-57.06%
2024	1.20	-21.39%
2023	1.52	-7.79%
2022	1.65	-28.83%
2021	2.32	-30.28%
2020	3.33	-22.20%
2019	4.28	24.56%
2018	3.43	173.39%
2017	1.26	20.04%
2016	1.05	-20.02%
2015	1.31	20.62%
2014	1.08	34.07%
2013	0.81	-0.50%
2012	0.81	155.32%
2011	0.32	-9.41%
2010	0.35	-8.79%
2009	0.39	9.70%
2008	0.35	-41.73%
2007	0.60	0.00%

Jaar

P/S-ratio

Wijzigen

2026 (TTM)

0.52

-57.06%

2024

1.20

-21.39%

2023

1.52

-7.79%

2022

1.65

-28.83%

2021

2.32

-30.28%

2020

3.33

-22.20%

2019

4.28

24.56%

2018

3.43

173.39%

2017

1.26

20.04%

2016

1.05

-20.02%

2015

1.31

20.62%

2014

1.08

34.07%

2013

0.81

-0.50%

2012

0.81

155.32%

2011

0.32

-9.41%

2010

0.35

-8.79%

2009

0.39

9.70%

2008

0.35

-41.73%

2007

0.60

0.00%

Bedrijf	P/S-ratio	Verschil in P/S-ratio	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	7.73	1,399.98%	IN

Bedrijf

P/S-ratio

Verschil in P/S-ratio

Land